- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/00 - Drugs for disorders of the nervous system
Patent holdings for IPC class A61P 25/00
Total number of patents in this class: 18233
10-year publication summary
|
655
|
706
|
1006
|
1189
|
1275
|
1333
|
1401
|
1395
|
1219
|
43
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7939 |
287 |
| Janssen Pharmaceutica N.V. | 3624 |
204 |
| Takeda Pharmaceutical Company Limited | 2945 |
182 |
| The Regents of the University of California | 19493 |
178 |
| Hoffmann-La Roche Inc. | 3255 |
127 |
| Glaxo Group Limited | 4283 |
113 |
| Novartis AG | 11289 |
110 |
| H. Lundbeck A/S | 1248 |
107 |
| AstraZeneca AB | 2961 |
102 |
| Neurosearch A/S | 206 |
94 |
| Daiichi Sankyo Company, Limited | 1864 |
87 |
| Centre National de La Recherche Scientifique | 10068 |
84 |
| sanofi-aventis | 395 |
84 |
| The Johns Hopkins University | 5524 |
82 |
| Pfizer Inc. | 3371 |
80 |
| Sage Therapeutics, Inc. | 349 |
79 |
| Boehringer Ingelheim International GmbH | 4756 |
74 |
| Bristol-myers Squibb Company | 4883 |
73 |
| Osaka University | 3293 |
68 |
| Merck Patent GmbH | 5847 |
59 |
| Other owners | 15959 |